A pilot study to assess the effect of beta blockade on exercise capacity and BNP levels in patients with predominantly diastolic heart failure

ISRCTN ISRCTN77645264
DOI https://doi.org/10.1186/ISRCTN77645264
Secondary identifying numbers N0226167747
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
28/10/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Nicholas Brooks
Scientific

South Manchester University Hospitals NHS Trust
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom

Phone +44 (0)161 291 2751/ 2752/ 2743
Email nicholas.brooks@smtr.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeQuality of life
Scientific titleA pilot study to assess the effect of beta blockade on exercise capacity and BNP levels in patients with predominantly diastolic heart failure
Study objectivesDoes the use of beta-blockers in patients with diastolic dysfunction and preserved systolic function result in a significant improvement in quality of life and exercise capacity, a significant reduction in plasma BNP levels, and improved CRP and interleukin levels?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCardiovascular: Heart failure
Intervention1. Bisoprolol (1.25 mg daily)
2. Placebo
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Bisoprolol
Primary outcome measureThe change from baseline in plasma BNP measurements
Secondary outcome measuresNot provided at time of registration
Overall study start date01/09/2005
Completion date19/12/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants40
Key inclusion criteriaA total of 40 patients with evidence or history of clinical heart failure, ejection fraction of >45% and raised plasma BNP levels.
Key exclusion criteria1. History of asthma / COPD
2. Hypotension, patients with significant bradycardia
3. BMI>30
4. Intolerant of beta-blockers, patients with constrictive pericarditis, with severe peripheral vascular disease, patients having suffered myocardial infarction within 3 months prior to enrolment
5. Pregnant women
6. Use of any investigational drug within 2 weeks of enrolment
7. Any recent changes in cardiac medications
Date of first enrolment01/09/2005
Date of final enrolment19/12/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

South Manchester University Hospitals NHS Trust
Manchester
M23 9LT
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

South Manchester University Hospitals NHS Trust

No information available

South Manchester University Hospitals NHS Trust

No information available

NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

28/10/2016: No publications found, verifying study status with principal investigator